Babesiosis- Red Blood Cell Exchange Transfusion in Pregnant Patient
Babesiosis- Red Blood Cell Exchange Transfusion in Pregnant Patient
Case Rep Obstet Gynecol. 2019 May 30;2019:9869323. doi: 10.1155/2019/9869323. eCollection 2019.
Abittan B1, Nizam A1, Oey M2, Callan F3, Simmonds L1, Pachtman SL1.
1 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Obstetrics and Gynecology, North Shore University Hospital, Manhasset, NY, USA.
2 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Internal Medicine, Division of Infectious Diseases, North Shore University Hospital, Manhasset, NY, USA.
3 Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Obstetrics and Gynecology, Huntington Hospital, Huntington, NY, USA.
Babesiosis, caused predominantly by Babesia microti, is an emerging health risk in the Northeastern and Midwestern United States. We present a case of a pregnant woman with history of splenectomy diagnosed with babesiosis at 23 5/7 weeks of gestational age refractory to antimicrobial therapy.
She underwent the first reported red blood cell exchange transfusion for babesiosis in pregnancy, at 24 4/7 weeks of gestational age, which resulted in resolution of parasitemia.
She had a full term, uncomplicated cesarean delivery.
Exchange transfusion is potentially a safe treatment option for severe babesiosis infection in pregnancy and should be considered when other methods are poorly tolerated or ineffective.
PMID: 31275683
PMCID: PMC6582862
DOI: 10.1155/2019/9869323
Link to Abstract Here
https://www.ncbi.nlm.nih.gov/pubmed/31275683